首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:American society of clinical oncology educational book / asco. american society of clinical oncolog

缩写:

ISSN:1548-8756

e-ISSN:

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引1256条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Jasmin Hundal,Abhinav Anand Vayal Veettil,Caroline Chung et al. Jasmin Hundal et al.
Artificial intelligence (AI) is increasingly integrated into oncology across clinical care, research workflows, and translational implementation. This chapter provides a practical overview of these domains, emphasizing opportunities and lim...
Eden Biltibo,Rajshekhar Chakraborty,Michael R Bishop Eden Biltibo
Bispecific antibodies (BsAb) are a class of T-cell-redirecting therapies used in a variety of advanced malignancies. BsAb can be associated with clinically significant toxicities, including cytokine release syndrome (CRS), immune effector c...
Eric Bouffet,David Neal Franz,Isabel Arrillaga-Romany et al. Eric Bouffet et al.
Advances in molecular and genomic techniques have significantly improved our understanding of pediatric brain tumors and enabled the development of targeted therapies directed at specific genetic alterations. The emergence of these therapie...
Miguel Zugman,Paulo V Campregher,Jeffrey S Ross et al. Miguel Zugman et al.
Precision oncology has fundamentally reshaped cancer treatment by enabling therapies to be matched to the molecular biology of individual tumors. Advances in next-generation sequencing (NGS) technologies, expanding biomarker discovery, and ...
Sophie Jessop,Hari Sankaran,Catrian Sotelo et al. Sophie Jessop et al.
This article examines persistent care gaps facing adolescents and young adults (AYAs) with sarcoma, focusing on clinical trial access, germline predisposition, and palliative care. Despite overall progress in oncology, AYAs continue to expe...
Parth Desai,Martin J Edelman,Sameera Kumar Parth Desai
Unresectable stage III non-small cell lung cancer (NSCLC) represents a biologically and clinically heterogeneous group of tumors. Concurrent chemoradiotherapy (cCRT) has long been the cornerstone of treatment for patients who are medically ...
Yajur Arya,Patrick Dyer,Fiona Hegi-Johnson et al. Yajur Arya et al.
Lung cancer remains the leading cause of cancer-related mortality worldwide. Although small cell lung cancer (SCLC) accounts for a smaller percentage of lung cancer cases, it has remained a significant contributor to the overall mortality b...
Bridgette Y Han,Emily H Wood,Manali I Patel Bridgette Y Han
Our global climate is changing-increasing the frequency, intensity, and duration of extreme-weather related disasters-with direct consequences on human health. These extreme weather-related events are not only environmental crises-they are ...
Kedar Kirtane,Harsh Dhar,Anil D&#x;Cruz et al. Kedar Kirtane et al.
Mortality and morbidity rates remain high in head and neck cancer (HNC). Novel radiopharmaceuticals, injectable therapies, advances in systemic therapy, including novel immunomodulators and cell-based therapies, and system-level changes to ...
Gerneiva Parkinson,Rima Patel,Colin Bergstrom et al. Gerneiva Parkinson et al.
Artificial intelligence (AI) is reshaping cancer research and clinical oncology by enabling large-scale analysis of complex biomedical data. Although early AI efforts focused on single-modality tasks such as imaging interpretation or pathol...